Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Glioma Glioblastoma Multiforme: early-phase trial registry
2 of 2 indexed Glioma Glioblastoma Multiforme trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Glioma Glioblastoma Multiforme: 2 US clinical trials tracked, 2 recruiting.
Glioma Glioblastoma Multiforme is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Tango Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition glioma-glioblastoma-multiforme
OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Glioma Glioblastoma Multiforme lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Glioma Glioblastoma Multiforme on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Glioma Glioblastoma Multiforme is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Tango Therapeutics
NCT06810544
WBSI Guided Personalized Delivery of TTFields
Abramson Cancer Center at Penn Medicine
NCT05086497
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Glioma Glioblastoma Multiforme records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Glioma Glioblastoma Multiforme trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Glioma Glioblastoma Multiforme page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Glioma Glioblastoma Multiforme trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Tango Therapeutics sponsors the most Glioma Glioblastoma Multiforme trials on record, review their full trial history before evaluating a specific study. See Tango Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Glioma Glioblastoma Multiforme condition card totals 2 registered trials; most-linked intervention Whole Brain Spectroscopy Imaging Array Mapping Layout; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.